DNA Script Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $89M
Latest Deal Amount
  • Investors
  • 14

DNA Script General Information

Description

Developer of an enzymatic DNA synthesis platform designed to facilitate genome-scale synthesis. The company's platform features a novel biochemical process for nucleic acids synthesis based on the use of highly efficient enzymes to provide rapid, high-quality production of important genomic experimental precursors, such as an oligonucleotide, enabling molecular biology researchers to accelerate their experiments and development of new therapeutics.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 67 avenue de Fontainebleau
  • Le Kremlin-Bicêtre
  • 94270
  • France
+33 01 00 00 00 00

DNA Script Timeline

2017201820192020
Financing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

DNA Script Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series B) 29-Jul-2020 $89M 00000 00000 Completed Generating Revenue
6. Grant 10-Jul-2018 00.00 000.00 Completed Generating Revenue
5. Grant 04-Apr-2018 00.00 000.00 Completed Generating Revenue
4. Grant 01-Feb-2018 00.000 000.00 Completed Generating Revenue
3. Early Stage VC (Series A) 12-Sep-2017 000.00 000.00 000.00 Completed Generating Revenue
2. Seed Round 30-May-2016 $2.82M $2.82M 00.000 Completed Generating Revenue
1. Accelerator/Incubator 01-Jul-2015 Completed Generating Revenue
To view DNA Script’s complete valuation and funding history, request access »

DNA Script Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
ADP 2019 00,000 00.000000 0000 0000 00 0000 00.000
ADP 2017 000,000 00.000000 000 000 00 000 00.000
ADP 2016 58,140 $0.100000 $43 $43 1x $43 14.6%
Ordinary 55,989 $0.100000
To view DNA Script’s complete cap table history, request access »

DNA Script Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of an enzymatic DNA synthesis platform designed to facilitate genome-scale synthesis. The company's platform f
Biotechnology
France
00000
0000 0000-00-00
00000000000 00000

0000000

commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu
0000000000000
London, United Kingdom
0 As of 0000
00.000
000000&0 00.000

000000 0

velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, s
00000 0000000000 0000000000 0000000
Saint Sulpice, Switzerland
000 As of 0000
00000
0000 0000-00-00
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

DNA Script Competitors (27)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Desktop Genetics Formerly VC-backed London, United Kingdom 0 00.000 000000&0 00.000
000000 00000000 Venture Capital-Backed Saint Sulpice, Switzerland 000 00000 00000000000 00000
00000000 Private Debt Financed Mountain View, CA 00 000000000 -
00000000000 Corporate Backed or Acquired Bothell, WA 000000&0
0000000 0000000 Venture Capital-Backed Boston, MA 000 00000 00000000000 00000
You’re viewing 5 of 27 competitors. Get the full list »

DNA Script Executive Team (3)

Name Title Board Seat Contact Info
Thomas Ybert Ph.D Co-Founder, Chief Executive Officer & Board Member
Sylvain Gariel Co-Founder, Chief Operating Officer & Board Member
Xavier Godron Co-Founder & Chief Technology Officer
To view DNA Script’s complete executive team members history, request access »

DNA Script Board Members (13)

Name Representing Role Since
Eli Casdin Self Board Member 000 0000
Heiner Dreismann Ph.D Kurma Partners Board Member 000 0000
Joachim Rothe Ph.D Self Board Member 000 0000
Joey Mason Self Board Observer 000 0000
Joško Bobanović Ph.D Sofinnova Partners Board Member 000 0000
You’re viewing 5 of 13 board members. Get the full list »

DNA Script Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Agilent Technologies Corporation Minority 000 0000 000000 0
Casdin Capital Hedge Fund Minority 000 0000 000000 0
Danaher Corporation Minority 000 0000 000000 0
Life Sciences Partners Venture Capital Minority 000 0000 000000 0
Merck Corporation Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »